197 related articles for article (PubMed ID: 34907157)
1. Genome-wide identification of microRNA targets reveals positive regulation of the Hippo pathway by miR-122 during liver development.
Zhang Y; Tan YY; Chen PP; Xu H; Xie SJ; Xu SJ; Li B; Li JH; Liu S; Yang JH; Zhou H; Qu LH
Cell Death Dis; 2021 Dec; 12(12):1161. PubMed ID: 34907157
[TBL] [Abstract][Full Text] [Related]
2. Argonaute CLIP Defines a Deregulated miR-122-Bound Transcriptome that Correlates with Patient Survival in Human Liver Cancer.
Luna JM; Barajas JM; Teng KY; Sun HL; Moore MJ; Rice CM; Darnell RB; Ghoshal K
Mol Cell; 2017 Aug; 67(3):400-410.e7. PubMed ID: 28735896
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA LOC107985656 represses the proliferation of hepatocellular carcinoma cells through activation of the tumor-suppressive Hippo pathway.
Zeng Y; Xu Q; Xu N
Bioengineered; 2021 Dec; 12(1):7964-7974. PubMed ID: 34565286
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
[TBL] [Abstract][Full Text] [Related]
5. MEIS2C and MEIS2D promote tumor progression via Wnt/β-catenin and hippo/YAP signaling in hepatocellular carcinoma.
Guan L; Li T; Ai N; Wang W; He B; Bai Y; Yu Z; Li M; Dong S; Zhu Q; Ding XX; Zhang S; Li M; Tang G; Xia X; Zhao J; Lin S; Yao S; Zhang L; Chen G; Liu FE; Li X; Zhang H
J Exp Clin Cancer Res; 2019 Oct; 38(1):417. PubMed ID: 31623651
[TBL] [Abstract][Full Text] [Related]
6. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis.
Au SL; Wong CC; Lee JM; Fan DN; Tsang FH; Ng IO; Wong CM
Hepatology; 2012 Aug; 56(2):622-31. PubMed ID: 22370893
[TBL] [Abstract][Full Text] [Related]
7. MiRNA-192 [corrected] and miRNA-204 Directly Suppress lncRNA HOTTIP and Interrupt GLS1-Mediated Glutaminolysis in Hepatocellular Carcinoma.
Ge Y; Yan X; Jin Y; Yang X; Yu X; Zhou L; Han S; Yuan Q; Yang M
PLoS Genet; 2015 Dec; 11(12):e1005726. PubMed ID: 26710269
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
[TBL] [Abstract][Full Text] [Related]
9. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis.
Nishina H
Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740
[TBL] [Abstract][Full Text] [Related]
10. miRNAs and the Hippo pathway in cancer: Exploring the therapeutic potential (Review).
Arora T; Kausar MA; Aboelnaga SM; Anwar S; Hussain MA; Sadaf S; Kaur S; Eisa AA; Shingatgeri VMM; Najm MZ; Aloliqi AA
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35699111
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of miR-144/451a cluster contributes to HCC progression via paracrine HGF/MIF-mediated TAM remodeling.
Zhao J; Li H; Zhao S; Wang E; Zhu J; Feng D; Zhu Y; Dou W; Fan Q; Hu J; Jia L; Liu L
Mol Cancer; 2021 Mar; 20(1):46. PubMed ID: 33658044
[TBL] [Abstract][Full Text] [Related]
12. The Hippo pathway effectors TAZ/YAP regulate dicer expression and microRNA biogenesis through Let-7.
Chaulk SG; Lattanzi VJ; Hiemer SE; Fahlman RP; Varelas X
J Biol Chem; 2014 Jan; 289(4):1886-91. PubMed ID: 24324261
[TBL] [Abstract][Full Text] [Related]
13. Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade.
Budel SJ; Penning MM; Penning LC
Vet Q; 2021 Dec; 41(1):172-180. PubMed ID: 33945400
[TBL] [Abstract][Full Text] [Related]
14. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation.
Cheng JC; Wang EY; Yi Y; Thakur A; Tsai SH; Hoodless PA
Mol Cancer Res; 2018 Oct; 16(10):1543-1555. PubMed ID: 29903770
[TBL] [Abstract][Full Text] [Related]
15. Hepatic Hippo signaling inhibits development of hepatocellular carcinoma.
Liu Y; Wang X; Yang Y
Clin Mol Hepatol; 2020 Oct; 26(4):742-750. PubMed ID: 32981290
[TBL] [Abstract][Full Text] [Related]
16. Herpesvirus saimiri MicroRNAs Preferentially Target Host Cell Cycle Regulators.
Guo YE; Oei T; Steitz JA
J Virol; 2015 Nov; 89(21):10901-11. PubMed ID: 26292323
[TBL] [Abstract][Full Text] [Related]
17. MiR-135b promotes HCC tumorigenesis through a positive-feedback loop.
Xin Y; Yang X; Xiao J; Zhao W; Li Y; Lu L; He X; Zhan M
Biochem Biophys Res Commun; 2020 Sep; 530(1):259-265. PubMed ID: 32828296
[TBL] [Abstract][Full Text] [Related]
18. AGO HITS-CLIP reveals distinct miRNA regulation of white and brown adipose tissue identity.
O'Connor S; Murphy EA; Szwed SK; Kanke M; Marchildon F; Sethupathy P; Darnell RB; Cohen P
Genes Dev; 2021 May; 35(9-10):771-781. PubMed ID: 33832988
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-375 Suppresses the Growth and Invasion of Fibrolamellar Carcinoma.
Dinh TA; Jewell ML; Kanke M; Francisco A; Sritharan R; Turnham RE; Lee S; Kastenhuber ER; Wauthier E; Guy CD; Yeung RS; Lowe SW; Reid LM; Scott JD; Diehl AM; Sethupathy P
Cell Mol Gastroenterol Hepatol; 2019; 7(4):803-817. PubMed ID: 30763770
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties.
Liu AM; Poon RT; Luk JM
Biochem Biophys Res Commun; 2010 Apr; 394(3):623-7. PubMed ID: 20226166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]